DVLCX
Price
$22.42
Change
-$0.22 (-0.97%)
Updated
Jun 13 closing price
Net Assets
381.29M
FSMDX
Price
$34.25
Change
-$0.44 (-1.27%)
Updated
Jun 13 closing price
Net Assets
40.4B
Interact to see
Advertisement

DVLCX vs FSMDX

Header iconDVLCX vs FSMDX Comparison
Open Charts DVLCX vs FSMDXBanner chart's image
BNY Mellon Opportunistic Midcap Value C
Price$22.42
Change-$0.22 (-0.97%)
VolumeN/A
Net Assets381.29M
Fidelity Mid Cap Index
Price$34.25
Change-$0.44 (-1.27%)
VolumeN/A
Net Assets40.4B
DVLCX vs FSMDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DVLCX vs. FSMDX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVLCX is a Hold and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 40.4B vs. DVLCX (381M). FSMDX pays higher dividends than DVLCX: FSMDX (1.14) vs DVLCX (0.00). DVLCX was incepted earlier than FSMDX: DVLCX (17 years) vs FSMDX (14 years). DVLCX (1.98) is less costly to investors than FSMDX (0.03). DVLCX is a more actively managed with annual turnover of: 58.67 vs. FSMDX (8.00). FSMDX has a lower initial minimum investment than DVLCX: FSMDX (0) vs DVLCX (1000). FSMDX annual gain was more profitable for investors over the last year : 11.45 vs. DVLCX (-5.95). FSMDX return over 5 years is better than : 75.56 vs. DVLCX (15.80).
DVLCXFSMDXDVLCX / FSMDX
Total Expense Ratio1.980.037,920%
Annual Report Gross Expense Ratio1.980.037,920%
Fund Existence17 years14 years-
Gain YTD1.6612.72461%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets381M40.4B1%
Annual Yield % from dividends0.001.14-
Returns for 1 year-5.9511.45-52%
Returns for 3 years1.7343.914%
Returns for 5 years15.8075.5621%
Returns for 10 years-39.99111.33-36%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSILX20.54N/A
N/A
iMGP Intl Instl
CNZLX11.66N/A
N/A
Commonwealth Australia/New Zealand
DEMZX24.86N/A
N/A
Macquarie Emerging Markets R6
MVISX43.12N/A
N/A
Patient Opportunity IS
AVANX14.91N/A
N/A
Avantis® International Small Cap Val G